ID   SMMU-1
AC   CVCL_DG22
SY   SMMUneg
DR   Wikidata; Q54954978
RX   PubMed=7511044;
RX   PubMed=8755562;
RX   PubMed=11214818;
RX   PubMed=16405722;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG23 ! SMMU-2
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=7511044;
RA   Guo Y.-J., Ma J., Wang J.-H., Che X.-Y., Narula J., Bigby M.,
RA   Wu M.-C., Sy M.-S.;
RT   "Inhibition of human melanoma growth and metastasis in vivo by
RT   anti-CD44 monoclonal antibody.";
RL   Cancer Res. 54:1561-1565(1994).
//
RX   PubMed=8755562; DOI=10.1073/pnas.93.15.7832; PMCID=PMC38834;
RA   Liu D.-C., Pearlman E., Diaconu E., Guo K., Mori H., Haqqi T.,
RA   Markowitz S.D., Willson J.K.V., Sy M.-S.;
RT   "Expression of hyaluronidase by tumor cells induces angiogenesis in
RT   vivo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7832-7837(1996).
//
RX   PubMed=11214818; DOI=10.1007/s004030000186;
RA   Trefzer U., Rietz N., Chen Y.-W., Audring H., Herberth G., Siegel P.,
RA   Reinke S., Koniger P., Wu S.-G., Ma J., Liu Y.-J., Wang H., Sterry W.,
RA   Guo Y.-J.;
RT   "SM5-1: a new monoclonal antibody which is highly sensitive and
RT   specific for melanocytic lesions.";
RL   Arch. Dermatol. Res. 292:583-589(2000).
//
RX   PubMed=16405722; DOI=10.1186/1471-2407-6-8; PMCID=PMC1351261;
RA   Trefzer U., Chen Y.-W., Herberth G., Hofmann M.A., Kiecker F.,
RA   Guo Y.-J., Sterry W.;
RT   "The monoclonal antibody SM5-1 recognizes a fibronectin variant which
RT   is widely expressed in melanoma.";
RL   BMC Cancer 6:8.1-8.12(2006).
//